Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial ; volume:14 ; number:1 ; day:17 ; month:1 ; year:2024 ; pages:1-8 ; date:12.2024
Translational Psychiatry ; 14, Heft 1 (17.1.2024), 1-8, 12.2024

Creator: Xia, Yanfang
Wehrli, Jelena
Abivardi, Aslan
Hostiuc, Madalina
Kleim, Birgit
Bach, Dominik R.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41398-024-02732-2

URN: urn:nbn:de:101:1-2404230833463.837580494599

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:46 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Xia, Yanfang
Wehrli, Jelena
Abivardi, Aslan
Hostiuc, Madalina
Kleim, Birgit
Bach, Dominik R.
SpringerLink (Online service)

Other Objects (12)

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Correction: Attenuating human fear memory retention with minocycline: a randomized placebo-controlled trial

Minocycline attenuates interferon-α-induced impairments in rat fear extinction

Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

Minocycline for sporadic and hereditary cerebral amyloid angiopathy (BATMAN): study protocol for a placebo-controlled randomized double-blind trial

Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial

Specific intracellular retention of circSKA3 promotes colorectal cancer metastasis by attenuating ubiquitination and degradation of SLUG

Minocycline attenuates experimental subarachnoid hemorrhage in rats

Minocycline differentially modulates human spatial memory systems

Fasting enhances extinction retention and prevents the return of fear in humans

Prevention of hypoglycemia-induced neuronal death by minocycline

Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial

Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Related objects

Reset password